Improving patient-provider communication for patients having surgery: patient perceptions of a revised health literacy-based consent process.

OBJECTIVES: This research sought to describe and compare perceptions of consent-related health communication between surgical patients undergoing procedures at facilities that did and did not adopt a new health literacy-based consent form and process. METHODS: A self-administered, mail survey was used to collect information about demographic characteristics, health locus of control, and perceptions of surgical consent-related health communication from patients aged 18 years or older, approximately 2 to 4 months after undergoing laparascopic cholecystectomy, total hip replacement, or total knee replacement surgery within a 10-hospital integrated health system in Iowa. A static group comparison design with multivariable logistic regression analyses was used to compare perceptions about 12 aspects of surgical consent-related health communication between the adopting and nonadopting facilities while controlling for observed differences in respondent background characteristics using a threshold of P < 0.05 for model inclusion. RESULTS: Respondents from facilities implementing the new consent form and process had significantly higher odds of strongly agreeing that the nurses asked them to restate the type of surgery being performed in their own words (adjusted odds ratio, 1.92; 95% confidence interval, 1.30-2.82) and they were comfortable asking questions about their surgery (adjusted odds ratio, 1.53; 95% confidence interval, 1.04-2.26). CONCLUSIONS: The consent process can be refined to stimulate communication and comfort with asking questions, and promote use of health literacy-based techniques (i.e., teach-back) in the perioperative care setting. Adopting a health literacy-based informed consent process promotes patient safety and supports health providers' obligations to communicate in simple, clear, and plain language.

Effects of premium discount on workers' compensation claims in agriculture in Finland.

BACKGROUND: The objective of this study was to measure changes in injury claim rates after a premium discount program was implemented in the Finnish farmers' workers' compensation insurance. We focused on measures that could indicate whether the changes occurred in the true underlying injury rate, or only in claims reporting. METHODS: Monthly injury claim rates were constructed at seven disability duration levels from January 1990 to December 2003. We conducted interrupted time series analyses to measure changes in the injury claim rates after the premium discount was implemented on July 1, 1997. Three additional policy change indicators were included in the analyses. RESULTS: The overall injury claim rate decreased 10.2%. Decreases occurred at four severity levels (measured by compensated disability days): 0 days (16.3%), 1-6 days (14.1%), 7-13 days (19.5%), and 14-29 days (8.4%). No changes were observed at higher severity levels. Minor injuries had a seasonal pattern with higher rates in summer months while severe injuries did not have a seasonal pattern. CONCLUSIONS: The premium discount decreased the overall claim rate. Decreases were observed in all categories up to 29 disability days. This pattern suggests that under-reporting contributes to the decrease but may not be the only factor. The value of the premium discount is lower than the value of a lost-time claim, so there was no financial reason to under-report lost-time injuries. Under-reporting would be expected to be greatest in the 0 day category, but that was not the case. These observations suggest that in addition to under-reporting, the premium discount may also have some preventive effect.

Albumin versus crystalloid therapy in the management of hepatorenal syndrome: a model for using meta analysis in cost effectiveness studies and the design of clinical trials.

We applied traditional methods of gathering, integrating and summarizing findings of current literature, with new approaches for assessing the cost effectiveness of two treatments for hepatorenal syndrome (HRS). Findings of this cost effectiveness study are used to form a proposal for a multi-center prospective clinical trial, to assess the economic and clinical benefits of albumen versus crystalloid therapy in the care of these patients. Our initial findings suggest that albumin therapy is superior to standard crystalloid therapy, in the treatment of HRS patients. The number of survival days appears to increase with this form of therapy per dollar cost, while patients await liver transplantation.